Posts filed under ‘GUIDELINES’

2018 GUIA – Prevención y diagnóstico de la Infección del Sitio Quirúrgico. Centro Nacional de Excelencia Tecnológica en Salud México

2018 GUIA – Prevención y diagnóstico de la Infección del Sitio Quirúrgico. Centro Nacional de Excelencia Tecnológica en Salud México. 49 pags

El Centro Nacional de Excelencia Tecnológica en Salud (CENETEC) de México presenta su guía para la prevención y diagnóstico de la infección de sitio quirúrgico. En su desarrollo, el documento responde a las siguientes preguntas de relevancia clínica:

1. ¿Cuáles son los factores de riesgo inherentes al paciente, para desarrollar infección de sitio quirúrgico?

2. ¿Cuáles son los factores de riesgo inherentes al procedimiento, para desarrollar infección de sitio quirúrgico?

3. ¿Cuál es la indicación de la descolonización por S. aureus meticilino resistente en pacientes quirúrgicos?

4. ¿Cuál es el mejor método de antisepsia para la preparación de la piel en el sitio quirúrgico?

5. ¿ Cómo influye el rasurado de la piel en el desarrollo de infección de la herida?

6. ¿Cuáles son las diferencias entre los agentes utilizados en el lavado de manos quirúrgico en la prevención de infección del sitio quirúrgico?

7. ¿En qué tipo de procedimiento está indicada la profilaxis antibiótica y cuál es al antibiótico de elección?

8. ¿Cuántas dosis de antibiótico son las recomendadas para profilaxis y en qué momento deben administrarse?

9. ¿Es efectiva la irrigación de las heridas como medio para reducir el riesgo de infección de la herida quirúrgica?

10. ¿Cuál es la eficacia de antibióticos tópicos en la prevención de infección en las heridas quirúrgicas de primera intención?

PDF

http://www.imss.gob.mx/sites/all/statics/guiasclinicas/827%20GER_InfeccionSitioQuirurgico_2018.pdf

 

 

Advertisements

February 20, 2019 at 4:07 pm

Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States.   January 4, 2019. 366 pag

Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States.   January 4, 2019.  366 pag

Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission – A Working Group of the Office of AIDS Research Advisory Council (OARAC)

What’s New in the Guidelines

Text, references, and appendices were updated to include new data and publications where relevant.

The sections that address infant feeding now include links to a new section that was added on March 27, 2018, titled Guidance for Counseling and Managing Women Living with HIV in the United States Who Desire to Breastfeed.

Major content changes are summarized below; all changes are highlighted throughout the guidelines.

PDF

http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf

January 8, 2019 at 8:08 am

Highlights From International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Infectious Diseases in Clinical Practice July 2011 V.19 N.4 P.282-283

Clinical Guidelines

File, Thomas M. Jr

A panel of international experts was convened by the Infectious Diseases Society of America in collaboration with the European Society for Microbiology and Infectious Diseases to update the 1999 uncomplicated urinary tract infection (UTI) guidelines.

The focus of the recommendations is on women with uncomplicated cystitis and pyelonephritis.

Since the 1999 guideline, antimicrobial resistance among uropathogens causing urinary tract infections has increased, and newer agents and different duration of therapy have been studied.

This update reflects many of the changes since the 1999 guideline.

FULL TEXT

https://journals.lww.com/infectdis/Fulltext/2011/07000/Highlights_From_International_Clinical_Practice.15.aspx

PDF (CLIC en PDF)

 

December 7, 2018 at 9:31 am

Highlights From Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Infectious Diseases in Clinical Practice May 2011 V.19 N.3 P.207-20

Clinical Guidelines

File, Thomas M. Jr

Recently, the Infectious Diseases Society published evidence-based guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections.

The guideline discusses the management of a variety of infections including skin infections, bacteremia and endocarditis, pneumonia, and osteomyelitis and joint infections.

FULL TEXT

https://journals.lww.com/infectdis/Fulltext/2011/05000/Highlights_From_Clinical_Practice_Guidelines_by.13.aspx

PDF (CLIC en PDF)

December 7, 2018 at 9:28 am

Managing an Elusive Pathogen: Treatment of Methicillin-Resistant Staphylococcus aureus Infections in a Variety of Care Settings

Infectious Diseases in Clinical Practice May 2011 V.19 N.3 P.150-155

NFID Clinical Updates

Poretz, Donald M.; Rehm, Susan J.

Methicillin-resistant Staphylococcus aureus (MRSA) infections continue to be a major problem both within hospitals (hospital-acquired MRSA) and increasingly in community settings (community-acquired MRSA), leading to well-publicized media reports and, as a result, greater public awareness of this problem.

Clinically, it is difficult to distinguish between a MRSA and a methicillin-sensitive S. aureus skin and soft tissue infection, and this should be taken into consideration when initiating empiric therapy.

There are several oral and intravenous antibiotics available to treat MRSA infections, some of which are inexpensive, whereas others are extremely costly; all have potential adverse effects and possible drug-drug interactions with which the prescriber should be familiar.

Careful monitoring of patients who receive outpatient intravenous antibiotics and an understanding of various intravenous devices and their associated possible complications in addition to knowledge of the economics involved are essential to make cost-effective decisions.

FULL TEXT

https://journals.lww.com/infectdis/Fulltext/2011/05000/Managing_an_Elusive_Pathogen__Treatment_of.2.aspx

PDF (CLIC en PDF)

December 7, 2018 at 9:24 am

2017 GUIA ARGENTINA PARA USO de ANTIBIOTICOS en el 1er Nivel Asistencial – MSN 181 pags.

Guía de medicamentos esenciales para el PNA – Antimicrobianos 1ra edición – Ciudad Autónoma de Buenos Aires : Ministerio de Salud de la Nación. Cobertura Universal de Salud. Medicamentos, 2017

“Guía de Medicamentos Esenciales en el PNA – Grupo Antimicrobianos” describe las características farmacológicas y clínicas más relevantes de los Medicamentos Esenciales utilizados en el manejo de las enfermedades infecciosas prevalentes en el primer nivel de atención.

La misma se agrupa a su vez en: antibióticos, antimicóticos, antivirales, antiparasitarios y fármacos para el tratamiento de la Tuberculosis.

PDF

http://www.msal.gob.ar/images/stories/bes/graficos/0000001087cnt-medicamentos-esenciales-primer-nivel-atencion-antimicrobianos.pdf

November 3, 2018 at 5:44 pm

NEUMONÍA ASOCIADA A VENTILACIÓN MECÁNICA. ACTUALIZACIÓN Y RECOMENDACIONES INTER-SOCIEDADES, SOCIEDAD ARGENTINA DE INFECTOLOGÍA – SOCIEDAD ARGENTINA DE TERAPIA INTENSIVA

Medicina (B Aires). 2018;78(2):99-106.

Pneumonia associated with mechanical ventilation. Update and recommendations inter- Societies SADI-SATI.

[Article in Spanish]

Cornistein W1, Colque ÁM2, Staneloni MI3, Monserrat Lloria M4, Lares M5, González AL5, Fernández Garcés A6, Carbone E7.

Author information

1 Hospital General de Agudos Dr. Cosme Argerich, Hospital Universitario Austral, Buenos Aires, Argentina. E-mail: wandacornistein@gmail.com.

2 Complejo Médico Churruca Visca, Buenos Aires, Argentina.

3 Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

4 Hospital Prof. Alejandro Posadas, Buenos Aires, Argentina.

5 Hospital Interzonal General de Agudos San Martín de La Plata, Argentina.

6 Clínica AMEBPBA (Mutual de Empleados del Banco de la Provincia de Buenos Aires), Argentina.

7 Hospital Aeronáutico Central, Buenos Aires, Argentina.

Abstract

Representatives of the Argentine Society of Infectious Diseases (SADI) and the Argentine Society of Intensive Therapy (SATI) worked together on the development of specific recommendations for the diagnosis, treatment and prevention of ventilator-associated pneumonia (VAP). The methodology used was the analysis of the literature published in the last 15 years, complemented with the opinion of experts and local data. This document aims to offer basic tools to optimize diagnosis based on clinical and microbiological criteria, orientation in empirical and targeted antibiotic schemes, news on posology and administration of antibiotics in critical patients and to promote effective measures to reduce the risk of VAP. It also offers a diagnostic and treatment algorithm and considerations on inhaled antibiotics. The joint work of both societies -infectious diseases and intensive care- highlights the concern for the management of VAP and the importance of ensuring improvement in daily practices. This guideline established recommendations to optimize the diagnosis, treatment and prevention of VAP in order to reduce morbidity and mortality, days of hospitalization, costs and resistance to antibiotics due to misuse of antimicrobials.

PDF

http://www.medicinabuenosaires.com/PMID/29659359.pdf

November 3, 2018 at 10:43 am

Older Posts


Calendar

February 2019
M T W T F S S
« Jan    
 123
45678910
11121314151617
18192021222324
25262728  

Posts by Month

Posts by Category